Cargando…
MDM2 is a Potential Target Gene of Glycyrrhizic Acid for Circumventing Breast Cancer Resistance to Tamoxifen: Integrative Bioinformatics Analysis
BACKGROUND: Tamoxifen is the drug of choice for treating breast cancer, particularly the estrogen receptor-positive luminal A subtype. However, the increased occurrence of Tamoxifen resistance highlights the need to develop an agent to enhance the effectiveness of this drug. OBJECTIVE: Although glyc...
Autores principales: | Azzahra, Salma Nur Azizah, Hanif, Naufa, Hermawan, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727350/ https://www.ncbi.nlm.nih.gov/pubmed/35901340 http://dx.doi.org/10.31557/APJCP.2022.23.7.2341 |
Ejemplares similares
-
Functional network analysis of p85 and PI3K as potential gene targets and mechanism of oleanolic acid in overcoming breast cancer resistance to tamoxifen
por: Ibadurrahman, Wilfan, et al.
Publicado: (2022) -
Integrative Bioinformatics Study of Tangeretin Potential Targets for Preventing Metastatic Breast Cancer
por: Hermawan, Adam, et al.
Publicado: (2021) -
Identification of potential target genes of honokiol in overcoming breast cancer resistance to tamoxifen
por: Hermawan, Adam, et al.
Publicado: (2022) -
Genomic Understanding Reveals the Important Role of FGFR2 as Paeoniflorin Target for Circumventing Breast Cancer Resistance to Tamoxifen
por: Wibowo, Moh Arikus, et al.
Publicado: (2021) -
Comprehensive Computational Analysis of Honokiol Targets for Cell Cycle Inhibition and Immunotherapy in Metastatic Breast Cancer Stem Cells
por: Skolastika, Skolastika, et al.
Publicado: (2022)